申熙江

  • 律师
  • T. +82-2-3404-0156
  • F. +82-2-3404-7307
  • E. heegang.shin@bkl.co.kr

介绍

Hee-Gang Shin's practices focus on capital market and corporate financing, M&A and restructuring of financial companies, approval and permit of financial companies and financial regulations, corporate M&A, corporate governance and holding companies, real estate financing/real estate indirect investment, private equity investment, foreign investment, asset securitization and structured finance, acquisition financing, general financing, asset management and collective investment, derivatives, project financing, and overseas investment.

Mr. Shin specializes in IPO and overseas securities and others regarding capital market and securities finance, and has advised SK Biopharmaceuticals, Kakao Games Corp., Big Hit Entertainment, Samsung Biologics, Doosan Bobcat, Cheil Industries, Hyundai-Rotem, LIG NEX1, Innocean Worldwide, CJ HelloVision on legal matters regarding large-scale IPO, and Psomagen, Englewood Lab, Accessbio and NeolmmuneTech of the U.S. and GRT and Organic Tea Cosmetics of China on their listing in Korea, China Eastern Airlines on issuance of Arirang Bonds and Industrial and Commercial Bank of China on issuance of Kimchi Bonds. He also has advised Hanwha Chemical Corporation, Industrial Bank of Korea, Youngone Corporation, Kolao Holdings on issuance of GDR and foreign exchange equalization bonds and KEPCO, KEXIM, KDB, NongHyup Bank, KB Kookmin Bank, LG Display, LG Chem on the issuance of overseas bonds and overseas equity linked bonds such as CB and EB, and Accessbio, CKH Food & Health Limited on the issuance of CB/BW for domestic and overseas investors. He was awarded as ‘The Securities Lawyer’ of the Year of the East Asia in 2017 by ‘The Asian Lawyer Award 2017’ of The Asian Lawyer and ‘Deal Maker of the Year’ by ALB Korea Award of ALB. In addition, he was selected as the ‘2020 Lawyers of the Year’ in the capital market field in 2020 by the Legal Times. Mr. Shin also advises Porsche on the establishment of a joint venture company in Korea, Samsung Asset Management on the acquisition of real estate in Germany and Korean companies on the investment in Germany and vice versa, and clients on establishment of joint venture companies and investment between Korea and Europe such as the establishment of a joint venture company named KAPES for technology transfer between KEPCO and Alstom.

Mr. Shin graduated Korea University (LL.B.) and completed the Judicial Research and Training Institute course. He also graduated Harvard Law School (LL.M.) in 2002 and worked at Kelley, Drye & Warren, LLP in New York. He was admitted to the bar of New York in 2003.

履历

2002-2003 Associate, Kelley, Drye & Warren LLP, New York
1997-至今 Bae, Kim & Lee LLC
1994-1997 Judge Advocate, Republic of Korea Army
其他经历
2019-至今 Member, KOSDAQ Listing Committee, Korea Exchange

主要业务案例

Advised the following clients on IPO: LG Energy Solution, Ltd., Kakao Pay Corp., KakaoBank Corp., KRAFTON, Inc., Hyundai Heavy Industries Co., Ltd., K Car Co., Ltd., SD Biosensor, Inc., HK inno.N Corp., SK Biopharmaceuticals Co., Ltd., Kakao Games Corp., Big Hit Entertainment Co., Ltd., Samsung Biologics Co., Ltd., Doosan Bobcat Inc., LIG NEX1 Co., Ltd., Innocean Worldwide Inc., CJ HelloVision Co., Ltd., Hyundai-Rotem Co., HUVIS Corporation, Interpark INT Corporation, It'S SKIN Co., Ltd., Celltrion Healthcare Co., Ltd., Cheil Industries Inc., Lotte Himart Co., Ltd., Hyundai HCN Co., Ltd., SK C&C Company Limited, Woongjin Energy Co., Ltd., HJ Magnolia Yongpyong Hotel & Resort Corporation, BGF retail Co., Ltd., Korea Autoglass Co., Ltd., LS Cable & System Asia Ltd., ECOPRO BM Co., Ltd.
Advised foreign companies or their holding companies on KRX IPO: Psomagen, Inc., Englewood Lab, Inc., Organic Tea Cosmetics Holdings Co., Ltd., Great Rich Technologies Limited, Access Bio, Inc., NeoImmuneTech, Inc., Wayport (H.K.) Co. Limited, Shenglong PV-TECH Investment Co., Ltd., LS Cable & System Asia Ltd., Doosan Bobcat Inc.
Advised the following clients on pre-IPO or financing after IPO: S&C Engine Group Limited, China Great Star International Limited, CKH Food & Health Limited, Access Bio, Inc., Wanli International Holdings Limited, RFHIC Corporation
Advised clients on the issuance of GDR: Hanwha Chemical Corporation, Industrial Bank of Korea, Youngone Corporation, Kolao Holdings, OCI Company Ltd., Hanatour Service Inc., Taewoong Co., Ltd.
Advised Korean and foreign companies on the listing in the U.S. and issuance of ADR: Hanaro Telecom Inc., GMARKET, Inc., Wemade Co., Ltd.
Advised the following clients on IPO: LG Energy Solution, Ltd., Kakao Pay Corp., KakaoBank Corp., KRAFTON, Inc., Hyundai Heavy Industries Co., Ltd., K Car Co., Ltd., SD Biosensor, Inc., HK inno.N Corp., SK Biopharmaceuticals Co., Ltd., Kakao Games Corp., Big Hit Entertainment Co., Ltd., Samsung Biologics Co., Ltd., Doosan Bobcat Inc., LIG NEX1 Co., Ltd., Innocean Worldwide Inc., CJ HelloVision Co., Ltd., Hyundai-Rotem Co., HUVIS Corporation, Interpark INT Corporation, It'S SKIN Co., Ltd., Celltrion Healthcare Co., Ltd., Cheil Industries Inc., Lotte Himart Co., Ltd., Hyundai HCN Co., Ltd., SK C&C Company Limited, Woongjin Energy Co., Ltd., HJ Magnolia Yongpyong Hotel & Resort Corporation, BGF retail Co., Ltd., Korea Autoglass Co., Ltd., LS Cable & System Asia Ltd., ECOPRO BM Co., Ltd.
Advised foreign companies or their holding companies on KRX IPO: Psomagen, Inc., Englewood Lab, Inc., Organic Tea Cosmetics Holdings Co., Ltd., Great Rich Technologies Limited, Access Bio, Inc., NeoImmuneTech, Inc., Wayport (H.K.) Co. Limited, Shenglong PV-TECH Investment Co., Ltd., LS Cable & System Asia Ltd., Doosan Bobcat Inc.
Advised the following clients on pre-IPO or financing after IPO: S&C Engine Group Limited, China Great Star International Limited, CKH Food & Health Limited, Access Bio, Inc., Wanli International Holdings Limited, RFHIC Corporation
Advised clients on the issuance of GDR: Hanwha Chemical Corporation, Industrial Bank of Korea, Youngone Corporation, Kolao Holdings, OCI Company Ltd., Hanatour Service Inc., Taewoong Co., Ltd.
Advised Korean and foreign companies on the listing in the U.S. and issuance of ADR: Hanaro Telecom Inc., GMARKET, Inc., Wemade Co., Ltd.
Advised foreign companies on change of control and M&A: Englewood Lab, Inc., Cosmecca korea Co., Ltd., Access Bio, Inc.
Advised the Korean government on issuance of foreign exchange equalization bonds
Advised clients on issuance of foreign currency bonds: Korea National Oil Corporation, KEPCO, Posco Co., Ltd., The Export-Import Bank of Korea, Korea South-East Power Co., Ltd., Korea Western Power Co., Ltd., Shinhan Card Co., Ltd., Asiana Airlines, Inc., Hyundai-Rotem Co., Dongkuk Steel Mill Co., Ltd., SK hynix Inc., NongHyup Bank Co., Ltd., LG Chem Ltd., LG Display Co., Ltd.
Advised clients on corporate restructuring: LG Card Co., Ltd., Sajo Daerim Co., Ltd., KOHAP Corporation, SK hynix Inc.
Advised clients on issuance of Arirang bonds: Industrial and Commercial Bank of China, China Eastern Airlines
Advised clients on acquisition financing, structuring financing, issuance of ABS and ABCP, project financing, overseas joint venture companies for introduction of technology, M&A and restructuring of financial institutions
Advised clients on acquisition financing: Himart Co., Ltd., Mando Corporation, WINIA Electronics Co., Ltd., Oriental Brewery Co., Ltd., MagnaChip Semiconductor Ltd.
Advised clients on joint venture for technology transfer: the establishment of KAPES, Inc., a joint venture of Korea Electric Power Corporation-Alstom SA, and establishment of KEPCO-Uhde Inc., a joint venture of Korea Electric Power Corporation-Thyssen Krupp AG
M&A: Advised on the sale of Intel's NAND flash business to SK Hynix (in progress), Cosmecca Korea's acquisition of Englewood Lab in the US, and the sale of management rights of Access Bio, a KOSDAQ-listed US company

学历

2002 Harvard Law School (LL.M.)
1994 Judicial Research and Training Institute, Supreme Court of Korea
1991 Korea University (LL.B.)

主要社会活动

著作
Issues Concerning Financial Contract Provisions: Understanding of Pro Rata Sharing Clause in the Syndicated Loan, BFL No. 35, pp. 20-31 (Co-author, Seoul National University Center for Financial Law, 2009)
Legal Issues Relating to the Execution of LBO Transaction, BFL No. 24, pp. 25-39 (Co-author, Seoul National University Center for Financial Law2007)
Introduction to Legal Issues Relating to Corporate Restructuring, Human Right and Justice No. 342 (Co-author, Korean Bar Association, 2005)
Summary Proceedings, International Association of Young Lawyers Series - Korea Section (Co-author, Kluwer Law International, 2000)
奖项
Chambers Asia-Pacific - Leading Lawyer (2016-2024)
Chambers Global - Leading Lawyer (2017-2023)
The Legal 500 - Leading Individual (2018-2019)
IFLR 1000 - Leading Lawyer (2017-2024)
Asialaw - Leading Lawyer (2016-2024)
Who's Who Legal - Leading Practitioner (2019-2024)
The Asia Legal Awards - Securities Lawyer of the Year (2017)

资格

2003 New York
1994 Korea

媒体评价

媒体评价